Dr. Gena H Volas-Redd, MD - Marietta ...

Dr. Gena H. Volas-Redd

Claim this profile

Northside Hospital

Studies Glioblastoma
Studies Breast Cancer
6 reported clinical trials
13 drugs studied

Area of expertise

1Glioblastoma
Gena H. Volas-Redd has run 2 trials for Glioblastoma. Some of their research focus areas include:
Stage I
Stage II
2Breast Cancer
Gena H. Volas-Redd has run 2 trials for Breast Cancer. Some of their research focus areas include:
Stage IV
Stage III
Stage I

Affiliated Hospitals

Image of trial facility.
Northside Hospital
Image of trial facility.
Northside Hospital - Gwinnett

Clinical Trials Gena H. Volas-Redd is currently running

Image of trial facility.

Stereotactic Radiosurgery vs Whole-Brain Radiotherapy

for Brain Metastasis from Lung Cancer

This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
Image of trial facility.

MRI Monitoring vs. Preventive Brain Radiation

for Small Cell Lung Cancer

This phase III trial studies magnetic resonance imaging (MRI) surveillance and prophylactic cranial irradiation (PCI) to see how well they work compared to MRI surveillance alone in treating patients with small cell lung cancer. MRI scans are used to monitor the possible spread of the cancer with an MRI machine over time. PCI is radiation therapy that is delivered to the brain in hopes of preventing spread of cancer into the brain. The use of brain MRI alone may reduce side effects of receiving PCI and prolong patients' lifespan. Monitoring with MRI scans alone (delaying radiation until the actual spread of the cancer) may be at least as good as the combination of PCI with MRI scans.
Recruiting2 awards Phase 322 criteria

More about Gena H. Volas-Redd

Clinical Trial Related2 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Gena H. Volas-Redd has experience with
  • Bevacizumab
  • Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
  • Atezolizumab
  • Paclitaxel
  • Pertuzumab
  • Trastuzumab

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Gena H. Volas-Redd specialize in?
Is Gena H. Volas-Redd currently recruiting for clinical trials?
Are there any treatments that Gena H. Volas-Redd has studied deeply?
What is the best way to schedule an appointment with Gena H. Volas-Redd?
What is the office address of Gena H. Volas-Redd?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security